Table II.
Multivariate Cox regression analysis of clinical parameters and CASC9 expression in TCGA cohort of patients with lung squamous cell carcinoma.
| Variablea | HR (95% CI) | P-value |
|---|---|---|
| CASC9 expression (high vs. low) | 1.308 (0.790-2.168) | 0.297 |
| Sex | 1.177 (0.681-2.034) | 0.560 |
| Age, years | 0.480 (0.269-0.855) | 0.013 |
| Tumor location | 1.850 (1.080-3.169) | 0.025 |
| Tumor stage | 1.886 (0.991-3.590) | 0.053 |
| Distant metastasis | 2.382 (0.321-17.689) | 0.396 |
| Lymph node metastasis | 0.842 (0.492-1.441) | 0.529 |
| Primary tumor stage | 1.582 (0.843-2.971) | 0.153 |
| Anatomical subdivision | 1.024 (0.874-1.201) | 0.768 |
a
The subcategories of the variables being compared are as listed in Table I. CASC9, cancer susceptibility candidate 9; HR, hazard ratio; CI, confidence interval.